AMGEN ANNOUNCES WEBCAST OF 2022 BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

Rhea-AI Summary

Amgen (NASDAQ:AMGN) will present at Bank of America Merrill Lynch's 2022 Global Healthcare Conference on Sept. 15, 2022, at 4:55 a.m. ET. CFO Peter H. Griffith will lead the presentation, which will be available via webcast for media and investors. Amgen, a leader in biotechnology, focuses on innovative therapeutics for serious illnesses and has been recognized for its workplace culture and sustainability efforts. The webcast will be accessible for replay for at least 90 days on Amgen's website. For more details, visit www.amgen.com.

Positive

• Amgen's CFO, Peter H. Griffith, will present at a notable healthcare conference, enhancing investor visibility.
• The webcast will be available for at least 90 days, allowing continued access to information for stakeholders.

Negative

• None.

THOUSAND OAKS, Calif., Sept. 12, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Bank of America Merrill Lynch's 2022 Global Healthcare Conference at 4:55 a.m. ET on Thursday,  Sept. 15, 2022. Peter H. Griffith, executive vice president and chief financial officer at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen 
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index.  In 2021, Amgen was named one of the 25 World's Best Workplaces™ by Fortune and Great Place to Work™ and one of the 100 most sustainable companies in the world by Barron's.

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Jessica Akopyan, 805-447-0974 (media) 
Arvind Sood, 805-447-1060 (investors) 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2022-bank-of-america-merrill-lynch-global-healthcare-conference-301622367.html

SOURCE Amgen

FAQ

When will Amgen present at the Bank of America Merrill Lynch Global Healthcare Conference?

Amgen will present on Sept. 15, 2022, at 4:55 a.m. ET.

Who will represent Amgen at the healthcare conference?

Peter H. Griffith, the Chief Financial Officer of Amgen, will present.

How can I access the Amgen conference presentation?

The presentation will be available via webcast on Amgen's website.

Is the Amgen webcast available after the event?

Yes, the webcast will be archived and available for replay for at least 90 days.

What is Amgen known for?

Amgen is recognized for its innovations in biotechnology and commitment to serious illness treatments.